In­vest­ing in bone heal­ing

Modern Healthcare - - The Week In Healthcare - Shawn Rhea

Medtronic has agreed to pay $123 mil­lion in cash to ac­quire Os­teotech, a de­vel­oper of bonere­gen­er­a­tion prod­ucts. The ac­qui­si­tion, ac­cord­ing to a news re­lease, will build the bone-heal­ing port­fo­lio within Medtronic’s bi­o­log­ics di­vi­sion. Ea­ton­town, N.J.-based Os­teotech, which has bone-graft and bio­com­pos­ite sur­gi­cal prod­ucts on the mar­ket, is seek­ing fed­eral ap­proval of a prod­uct that uses en­gi­neered hu­man col­la­gen bio­ma­te­ri­als. The ac­qui­si­tion of­fer is sub­ject to ap­proval by Os­teotech’s share­hold­ers and cus­tom­ary reg­u­la­tory ap­provals. The deal calls for Minneapolis-based Medtronic to pay $6.50 per share.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.